Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

L-citrulline intravenous - Asklepion Pharmaceuticals/Vanderbilt-University

Drug Profile

L-citrulline intravenous - Asklepion Pharmaceuticals/Vanderbilt-University

Alternative Names: L-citrulline

Latest Information Update: 15 Jan 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vanderbilt University
  • Developer Asklepion Pharmaceuticals; Vanderbilt University
  • Class Amino acids; Diamino amino acids; Small molecules
  • Mechanism of Action Amino acid replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Acute lung injury

Most Recent Events

  • 01 Jul 2019 Asklepion Pharmaceuticals completes enrolment in its phase III trial for Acute lung injury (In infants, In children, In adolescents, Prevention) in USA, Austria, Israel, Germany (NCT02891837)
  • 26 Apr 2019 Asklepion Pharmaceuticals has patent protection for a method for using intravenous citrulline to reduce the incidence of cardiopulmonary bypass-induced pulmonary injury in USA
  • 05 Jan 2018 Chemical structure information added
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top